Inhibition of both CXCL12 and ER resulted in decreased proliferation and migration [193], suggesting that CXCL12 differentially regulates proliferation and migration in breast cancer depending on the expression levels of ER. This evidence concerns the gene ESR1 and breast carcinoma.